The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells

Journal of Biological Chemistry

Volumn 289, Issue 19, 2014, Pages 13461-13474

  Hiemer, Samantha E ^a   Szymaniak, Aleksander D ^a   Varelas, Xaralabos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; ENZYME INHIBITION;

BREAST CANCER CELLS; EXPRESSION ANALYSIS; INDUCED SIGNAL; NONTUMORIGENIC CELLS; TRANSCRIPTIONAL CHANGES; TRANSCRIPTIONAL PROGRAM; TRANSCRIPTIONAL REGULATOR; TRANSFORMING GROWTH FACTORS;

CELL SIGNALING;

SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD; TRANSCRIPTIONAL REGULATOR TAZ; TRANSCRIPTIONAL REGULATOR YAP; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME; MOLECULAR INTERACTION; NEGR1 GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UCA1 GENE;

BREAST CANCER; CELL MIGRATION; CELL SIGNALING; COREGULATOR TRANSCRIPTION; HIPPO PATHWAY; SIGNAL TRANSDUCTION; SIGNALING CROSS-TALK; TRANSFORMING GROWTH FACTOR Β (TGFΒ); YAP/TAZ;

BREAST NEOPLASMS; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GPI-LINKED PROTEINS; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RNA, LONG NONCODING; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84900424727     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.529115     Document Type: Article

References (73)

1. Harvey, K. F., Zhang, X., and Thomas, D. M. (2013) The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257
2. Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., Daidone, M. G., Dupont, S., Basso, G., Bicciato, S., and Piccolo, S. (2011) The hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772
3. Vlug, E. J., van de Ven, R. A., Vermeulen, J. F., Bult, P., van Diest, P. J., and Derksen, P. W. (2013) Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer. Cell. Oncol. 36, 375-384
4. Wang, X., Su, L., and Ou, Q. (2012) Yes-Associated protein promotes tumour development in luminal epithelial derived breast cancer. Eur. J. Cancer 48, 1227-1234
5. Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., and Hong, W. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592-2598
6. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., and Pan, D. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133
7. Lei, Q. Y., Zhang, H, Zhao, B., Zha, Z. Y., Bai, F., Pei, X. H., Zhao, S., Xiong, Y., and Guan, K. L. (2008) TAZ promotes cell proliferation and epithelialmesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28, 2426-2436
8. Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C. X., Brugge, J. S., and Haber, D. A. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U. S. A. 103, 12405-12410
9. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761
10. Lamar, J. M., Stern, P., Liu, H., Schindler, J. W., Jiang, Z. G., and Hynes, R. O. (2012) The hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl. Acad. Sci. U. S. A. 109, E2441-2450
11. Lai, D., Ho, K. C., Hao, Y., and Yang, X. (2011) Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 71, 2728-2738
12. Zhang, H., Liu, C. Y., Zha, Z. Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2009) TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355-13362
13. Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C. Y., Chinnaiyan, A. M., Lai, Z. C, and Guan, K. L. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971
14. Xie, D., Nakachi, K., Wang, H., Elashoff, R., and Koeffler, H. P. (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61, 8917-8923
15. Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505
16. Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C, and Yaffe, M. B. (2000) TAZ: a novel transcriptional co-Activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBOJ. 19, 6778-6791
17. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., and Downward, J. (2003) Akt phosphorylates the Yes-Associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11-23
18. Liu, C Y., Zha, Z. Y., Zhou, X., Zhang, H, Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C J., Hong, W., Zhao, S., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169
19. Zhao, B., Li, L., Tumaneng, K., Wang, C. Y., and Guan, K. L. (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF (β-TRCP). Genes Dev. 24, 72-85
20. Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M., and Piccolo, S. (2012) Role of TAZ as mediator of Wnt signaling. Cell 151, 1443-1456
21. Huang, W., Lv, X., Liu, C, Zha, Z., Zhang, H., Jiang, Y., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2012) The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J. Biol. Chem. 287, 26245-26253
22. Mauviel, A., Nallet-Staub, F., and Varelas, X. (2012) Integrating developmental signals: a hippo in the (path) way. Oncogene 31, 1743-1756
23. Wu, M. Y., and Hill, C. S. (2009) Tgf-β superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329-343
24. Abdollah, S., Macías-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., and Wrana, J. L. (1997) TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272, 27678-27685
25. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997) TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362
26. Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B. M., Dembowy, J., Yaffe, M. B., Zandstra, P. W., and Wrana, J. L. (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol. 10, 837-848
27. Bierie, B., and Moses, H. L. (2006) Tumour microenvironment: TGF/3: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520
28. Massagué, J. (2008) TGFβ in Cancer. Cell 134, 215-230
29. Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N, Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., Halushka, M. K., Sukumar, S., Parker, L. M., Anderson, K. S., Harris, L. N, Garber, J. E., Richardson, A. L., Schnitt, S. J., Nikolsky, Y., Gelman, R. S., and Polyak, K. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273
30. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N, Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C, Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C, Yang, J., and Weinberg, R. A. (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715
31. Fujii, M., Toyoda, T., Nakanishi, H, Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H., and Sekido, Y. (2012) TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J. Exp. Med. 209, 479-494
32. Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B. G., Rossant, J., and Wrana, J. L. (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev. Cell 19, 831-844
33. Aranda, V., Haire, T., Nolan, M. E., Calarco, J. P., Rosenberg, A. Z., Fawcett, J. P., Pawson, T., and Muthuswamy, S. K. (2006) Par6-APKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol. 8, 1235-1245
34. de Hoon, M. J., Imoto, S., Nolan, J., and Miyano, S. (2004) Open source clustering software. Bioinformatics 20, 1453-1454
35. Beyer, T. A., Weiss, A., Khomchuk, Y., Huang, K., Ogunjimi, A. A., Varelas, X., and Wrana, J. L. (2013) Switch enhancers interpret TGF-β and hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5, 1611-1624
36. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
37. Wu, J., Mukherjee, A., Lebman, D. A., and Fang, X. (2011) Lysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ. Mol. Cancer Res. 9, 1562-1570
38. Choki, I., Sourla, A., Reyes-Moreno, C, and Koutsilieris, M. (1998) Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res. 18, 4213-4224
39. Dai, M., Al-Odaini, A. A., Arakelian, A., Rabbani, S. A., Ali, S., and Lebrun, J. J. (2012) A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion. Breast Cancer Res. 14, R127
40. Frey, R. S., and Mulder, K. M. (1997) TGFβ regulation of mitogen-Activated protein kinases in human breast cancer cells. Cancer Lett. 117, 41-50
41. Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C, and Barcellos-Hoff, M. H. (2011) TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin. Cancer Res. 17, 6754-6765
42. Chen, C. R., Kang, Y., and Massagué, J. (2001) Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program. Proc. Natl. Acad. Sci. U. S. A. 98, 992-999
43. Ohmori, T., Yang, J. L., Price, J. O., and Arteaga, C. L. (1998) Blockade of tumor cell transforming growth factor-βs enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Exp. Cell Res. 245, 350-359
44. Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C. R., Manova-Todorova, K., Blasberg, R., Gerald, W. L., and Massagué, J. (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U. S. A. 102, 13909-13914
45. Munoz, R., Man, S., Shaked, Y., Lee, C. R., Wong, J., Francia, G., and Kerbel, R. S. (2006) Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res. 66, 3386-3391
46. Cailleau, R., Olivé, M., and Cruciger, Q. V. (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911-915
47. Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., and Wicha, M. S. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270
48. Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., Gaster, L., Callahan, J. F., and Olson, B. A. (2002) Inhibition of transforming growth factor (TGF) - β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58-64
49. Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N J., and Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74
50. Bakin, A. V., Rinehart, C, Tomlinson, A. K., and Arteaga, C L. (2002) p38 mitogen-Activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115, 3193-3206
51. Wieser, R., Wrana, J. L., and Massagué, J. (1995) GS domain mutations that constitutively activate T/3R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208
52. Koos, B., Andersson, L., Clausson, C. M., Grannas, K., Klaesson, A., Cane, G., and Soderberg, O. (2013) Analysis of Protein Interactions in situ by Proximity Ligation Assays. Curr. Top. Microbiol. Immunol. 10.1007/82-2013-334
53. Funatsu, N, Miyata, S., Kumanogoh, H, Shigeta, M., Hamada, K., Endo, Y., Sokawa, Y., and Maekawa, S. (1999) Characterization of a novel rat brain glycosylphosphatidylinositol-Anchored protein (Kilon), a member of the IgLON cell adhesion molecule family. J. Biol. Chem. 274, 8224-8230
54. Hashimoto, T., Maekawa, S., and Miyata, S. (2009) IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons. CellBiochem. Funct. 27, 496-498
55. Levitt, P. (1984) A monoclonal antibody to limbic system neurons. Science 223, 299-301
56. Marg, A., Sirim, P., Spaltmann, F., Plagge, A., Kauselmann, G., Buck, F., Rathjen, F. G., and Brümmendorf, T. (1999) Neurotractin, a novel neurite outgrowth-promoting Ig-like protein that interacts with CEPU-1 and LAMP. J. Cell Biol. 145, 865-876
57. Pimenta, A. F., Zhukareva, V., Barbe, M. F., Reinoso, B. S., Grimley, C, Henzel, W., Fischer, I., and Levitt, P. (1995) The limbic system-Associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting. Neuron 15, 287-297
58. Spaltmann, F., and Brümmendorf, T. (1996) CEPU-1, a novel immunoglobulin superfamily molecule, is expressed by developing cerebellar Purkinje cells. J. Neurosci. 16, 1770-1779
59. Struyk, A. F., Canoll, P. D., Wolfgang, M. J., Rosen, C. L., D'Eustachio, P., and Salzer, J. L. (1995) Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules. J. Neurosci. 15, 2141-2156
60. Wang, F., Li, X., Xie, X., Zhao, L., and Chen, W. (2008) UCA1, a nonprotein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 582, 1919-1927
61. Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., Chinnaiyan, A., Israel, M. A., Goldstein, L. S., Abujarour, R., Ding, S., and Guan, K. L. (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. GenesDev. 24, 1106-1118
62. Shi, Y., and Massagué, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700
63. Brown, K. A., Aakre, M. E., Gorska, A. E., Price, J. O., Eltom, S. E., Pietenpol, J. A., and Moses, H. L. (2004) Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res. 6, R215-231
64. Iavarone, A., and Massagué, J. (1997) Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417-422
65. Yang, N., Morrison, C. D., Liu, P., Miecznikowski, J., Bshara, W., Han, S., Zhu, Q., Omilian, A. R., Li, X., and Zhang, J. (2012) TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle 11, 2922-2930
66. Zhang, J., Ji, J. Y., Yu, M., Overholtzer, M., Smolen, G. A., Wang, R., Brugge, J. S., Dyson, N. J., and Haber, D. A. (2009) YAP-dependent induction of amphiregulin identifies anon-cell-Autonomous component of the hippo pathway. Nat CellBiol. 11, 1444-1450
67. Leask, A., Sa, S., Holmes, A., Shiwen, X., Black, C. M., and Abraham, D. J. (2001) The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol. Pathol. 54, 180-183
68. Watanabe, Y., Itoh, S., Goto, T., Ohnishi, E., Inamitsu, M., Itoh, F., Satoh, K., Wiercinska, E., Yang, W., Shi, L., Tanaka, A., Nakano, N., Mommaas, A. M., Shibuya, H., Ten Dijke, P., and Kato, M. (2010) TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol. Cell 37, 123-134
69. Bayarmagnai, B., Nicolay, B. N., Islam, A. B., Lopez-Bigas, N., and Frolov, M. V. (2012) Drosophila GAGA factor is required for full activation of the dE2f1-Yki/Sd transcriptional program. Cell Cycle 11, 4191-4202
70. Oh, H, Slattery, M., Ma, L., Crofts, A., White, K. P., Mann, R. S., and Irvine, K. D. (2013) Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. CellRep. 3, 309-318
71. Nishioka, N., Inoue, K., Adachi, K., Kiyonari, H., Ota, M., Ralston, A., Yabuta, N., Hirahara, S., Stephenson, R. O., Ogonuki, N., Makita, R., Kurihara, H., Morin-Kensicki, E. M., Nojima, H, Rossant, J., Nakao, K., Niwa, H, and Sasaki, H. (2009) The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398-410
72. Connolly, E. C., Freimuth, J., and Akhurst, R. J. (2012) Complexities of TGF-β targeted cancer therapy. Int. J. Biol. Sci. 8, 964-978
73. Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S. J., Anders, R. A., Liu, J. O., and Pan, D. (2012) Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300-1305